INS and type 1 diabetes mellitus: Participants on insulin therapy for more than 10 years; fasting circulating C-peptide of less than 600 pmol/L; type 1 diabetes; significant diabetes-related microvascular complications; estimated glomerular filtration rate (eGFR) less than 30 mL/min/1.73 m2; clinically diagnosed binge eating disorder​.